Investment of the Day
Orchard raises 150 million dollar to expand after GSK gene therapy deal
LONDON: Anglo-American biotech company Orchard Therapeutics has raised a further $150 million (117.7 million pounds) to fund its w... Read more »Latest News
-
Glenmark inks pact with private equity firm True North
New Delhi: Glenmark Pharmaceuticals said it has entered into a collaboration with private equity fi... -
China, Korea overtaking India in vaccine exports: Experts
HYDERABAD: India, once called as the vaccine capital, is slowly losing its sheen because of... -
Alnylam's gene silencing drug wins FDA approval
Alnylam Pharmaceuticals Inc’s drug for a rare hereditary disease won U.S. regulatory approval, bec... -
Biogen's pricey muscle drug Spinraza too costly for Britain
LONDON: Biogen's muscle disease treatment Spinraza has been deemed too expensive for use on Brit... -
Bayer shares fall 10 pct after Monsanto's Roundup cancer trial
FRANKFURT: Bayer shares plunged more than 10 percent after a California jury ordered the German com... -
Telangana attracts over Rs 10,000 crore in Life Sciences in 4 years
Hyderabad: Telangana, already home to pharma majors such as Aurobindo Pharma and Dr Reddy's, attra...
